| Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management AU Anka, MI Tahir, SD Abubakar, M Alsabbagh, Z Zian, H Hamedifar, ... Scandinavian journal of immunology 93 (4), e12998, 2021 | 408 | 2021 |
| A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders AN Kamali, SM Noorbakhsh, H Hamedifar, F Jadidi-Niaragh, R Yazdani, ... Molecular immunology 105, 107-115, 2019 | 197 | 2019 |
| Biscoumarin-1, 2, 3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies MS Asgari, M Mohammadi-Khanaposhtani, M Kiani, PR Ranjbar, E Zabihi, ... Bioorganic chemistry 92, 103206, 2019 | 97 | 2019 |
| The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases SPDG Berry, C Dossou, A Kashif, N Sharifinejad, G Azizi, H Hamedifar, ... International immunopharmacology 102, 108402, 2022 | 85 | 2022 |
| A review on synthesis, mechanism of action, and structure-activity relationships of 1, 2, 3-triazole-based α-glucosidase inhibitors as promising anti-diabetic agents Z Fallah, M Tajbakhsh, M Alikhani, B Larijani, MA Faramarzi, H Hamedifar, ... Journal of Molecular Structure 1255, 132469, 2022 | 75 | 2022 |
| Synthesis and biological evaluation of new benzimidazole-1, 2, 3-triazole hybrids as potential α-glucosidase inhibitors N Asemanipoor, M Mohammadi-Khanaposhtani, S Moradi, M Vahidi, ... Bioorganic chemistry 95, 103482, 2020 | 74 | 2020 |
| Synthesis, characterization, molecular docking, and biological activities of coumarin–1, 2, 3‐triazole‐acetamide hybrid derivatives N Sepehri, M Mohammadi‐Khanaposhtani, N Asemanipoor, S Hosseini, ... Archiv der Pharmazie 353 (10), 2000109, 2020 | 69 | 2020 |
| The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity N Sepehri, A Iraji, A Yavari, MS Asgari, S Zamani, S Hosseini, ... Bioorganic & Medicinal Chemistry 36, 116044, 2021 | 54 | 2021 |
| Synthesis and pharmacological properties of polysubstituted 2-amino-4H-pyran-3-carbonitrile derivatives Z Tashrifi, M Mohammadi-Khanaposhtani, H Hamedifar, B Larijani, ... Molecular Diversity 24, 1385-1431, 2020 | 52 | 2020 |
| The potential role of pro-inflammatory and anti-inflammatory cytokines in epilepsy pathogenesis AN Kamali, Z Zian, JM Bautista, H Hamedifar, N Hossein-Khannazer, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 46 | 2021 |
| Recent strategies in the synthesis of thiophene derivatives: highlights from the 2012–2020 literature F Abedinifar, E Babazadeh Rezaei, M Biglar, B Larijani, H Hamedifar, ... Molecular Diversity 25, 2571-2604, 2021 | 42 | 2021 |
| Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis FS Rizvi, H Zainaldain, H Rafiemanesh, M Jamee, N Hossein-Khannazer, ... Expert review of clinical immunology 16 (12), 1227-1235, 2020 | 36 | 2020 |
| Synthesis and characterization of γ-Fe 2 O 3@ SiO 2–(CH 2) 3–PDTC–Pd magnetic nanoparticles: A new and highly active catalyst for the Heck/Sonogashira coupling reactions Z Tashrifi, S Bahadorikhalili, H Lijan, S Ansari, H Hamedifar, M Mahdavi New Journal of Chemistry 43 (23), 8930-8938, 2019 | 35 | 2019 |
| A new series of Schiff base derivatives bearing 1, 2, 3‐triazole: Design, synthesis, molecular docking, and α‐glucosidase inhibition E Nasli‐Esfahani, M Mohammadi‐Khanaposhtani, S Rezaei, Y Sarrafi, ... Archiv der Pharmazie 352 (8), 1900034, 2019 | 33 | 2019 |
| Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS‐like diseases: A systematic review N Hafezi, M Zaki‐Dizaji, M Nirouei, G Asadi, N Sharifinejad, M Jamee, ... Pediatric Allergy and Immunology 32 (7), 1519-1532, 2021 | 30 | 2021 |
| Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes M Askarzadeh, H Azizian, M Adib, M Mohammadi-Khanaposhtani, ... Scientific Reports 12 (1), 10569, 2022 | 28 | 2022 |
| Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review N Sharifinejad, M Zaki-Dizaji, S Tebyanian, H Zainaldain, M Jamee, ... Expert Review of Clinical Immunology 17 (8), 807-817, 2021 | 27 | 2021 |
| α-Glucosidase and α-amylase inhibition, molecular modeling and pharmacokinetic studies of new quinazolinone-1, 2, 3-triazole-acetamide derivatives A Yavari, M Mohammadi-Khanaposhtani, S Moradi, S Bahadorikhalili, ... Medicinal Chemistry Research 30, 702-711, 2021 | 26 | 2021 |
| Design, synthesis and biological evaluation of novel phthalimide-Schiff base-coumarin hybrids as potent α-glucosidase inhibitors M Sherafati, M Mohammadi-Khanaposhtani, S Moradi, MS Asgari, ... Chemical Papers 74, 4379-4388, 2020 | 24 | 2020 |
| Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors A Nasli Esfahani, A Iraji, A Alamir, S Moradi, MS Asgari, S Hosseini, ... Molecular Diversity, 1-15, 2021 | 22 | 2021 |